Therapeutic potential of phytochemicals for cystic fibrosis

被引:4
|
作者
Baharara, Hamed [1 ]
Kesharwani, Prashant [2 ,3 ]
Johnston, Thomas P. [4 ]
Sahebkar, AmirHossein [5 ,6 ,7 ]
机构
[1] Mashhad Univ Med Sci, Sch Pharm, Dept Clin Pharm, Mashhad, Iran
[2] Jamia Hamdard, Sch Pharmaceut Educ & Res, Dept Pharmaceut, New Delhi, India
[3] Saveetha Inst Med & Tech Sci, Saveetha Dent Coll, Ctr Transdisciplinary Res, Dept Pharmacol, Chennai, India
[4] Univ Missouri Kansas City, Sch Pharm, Div Pharmacol & Pharmaceut Sci, Kansas City, MO USA
[5] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Iran
[6] Mashhad Univ Med Sci, Appl Biomed Res Ctr, Mashhad, Iran
[7] Mashhad Univ Med Sci, Sch Pharm, Dept Biotechnol, Mashhad, Iran
关键词
baicalein; capsaicin; coumarin; curcumin; cystic fibrosis; genistein; phytomedicine; quercetin; resveratrol; TRANSMEMBRANE CONDUCTANCE REGULATOR; NATURAL COMPOUND CURCUMIN; CHLORIDE-CHANNEL; WILD-TYPE; SURFACE EXPRESSION; NUCLEOTIDE-BINDING; DELTA-F508; CFTR; CELL-CULTURE; IN-VITRO; GENISTEIN;
D O I
10.1002/biof.1960
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aim of this review was to review and discuss various phytochemicals that exhibit beneficial effects on mutated membrane channels, and hence, improve transmembrane conductance. These therapeutic phytochemicals may have the potential to decrease mortality and morbidity of CF patients. Four databases were searched using keywords. Relevant studies were identified, and related articles were separated. Google Scholar, as well as gray literature (i.e., information that is not produced by commercial publishers), were also checked for related articles to locate/identify additional studies. The relevant databases were searched a second time to ensure that recent studies were included. In conclusion, while curcumin, genistein, and resveratrol have demonstrated effectiveness in this regard, it should be emphasized that coumarins, quercetin, and other herbal medicines also have beneficial effects on transporter function, transmembrane conductivity, and overall channel activity. Additional in vitro and in vivo studies should be conducted on mutant CFTR to unequivocally define the mechanism by which phytochemicals alter transmembrane channel function/activity, since the results of the studies evaluated in this review have a high degree of heterogenicity and discrepancy. Finally, continued research be undertaken to clearly define the mechanism(s) of action and the therapeutic effects that therapeutic phytochemicals have on the symptoms observed in CF patients in an effort to reduce mortality and morbidity.
引用
收藏
页码:984 / 1009
页数:26
相关论文
共 50 条
  • [31] Potential Therapeutic Strategies of Phytochemicals in Neurodegenerative Disorders
    Yadav, Dharmendra Kumar
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2021, 21 (31) : 2814 - 2838
  • [32] Conifers Phytochemicals: A Valuable Forest with Therapeutic Potential
    Bhardwaj, Kanchan
    Silva, Ana Sanches
    Atanassova, Maria
    Sharma, Rohit
    Nepovimova, Eugenie
    Musilek, Kamil
    Sharma, Ruchi
    Alghuthaymi, Mousa A.
    Dhanjal, Daljeet Singh
    Nicoletti, Marcello
    Sharma, Bechan
    Upadhyay, Navneet Kumar
    Cruz-Martins, Natalia
    Bhardwaj, Prerna
    Kuca, Kamil
    MOLECULES, 2021, 26 (10):
  • [33] Therapeutic Potential of Phenolic Phytochemicals in Diabetes Mellitus
    Md. Fahim Ahmad
    Inamur Rahman
    Nida Naseem
    Nazia Imam
    Hina Younus
    Haseeb Ahsan
    Waseem A. Siddiqui
    Resonance, 2024, 29 (10) : 1389 - 1399
  • [34] Cystic fibrosis transmembrane conductance regulator protein repair as a therapeutic strategy in cystic fibrosis
    Sloane, Peter A.
    Rowe, Steven M.
    CURRENT OPINION IN PULMONARY MEDICINE, 2010, 16 (06) : 591 - 597
  • [35] COMPARISON OF NASAL POTENTIAL DIFFERENCE AND INTESTINAL CURRENT MEASUREMENTS AS POTENTIAL THERAPEUTIC ENDPOINT MEASURES IN CYSTIC FIBROSIS
    Omari, I
    Yaakov, Y.
    Zaman, M.
    Martin, C.
    Cohen-Cymberknoh, M.
    Shoseyov, D.
    Kerem, E.
    Freedman, S.
    Wilschanski, M.
    PEDIATRIC PULMONOLOGY, 2011, : 289 - 289
  • [36] Substituted phenylthioureas are novel inhibitors of myeloperoxidase: Potential therapeutic agents for treating cystic fibrosis
    Eiserich, J.
    Rathnayake, S.
    Houghton, J.
    Muzikar, M.
    Toney, M.
    PEDIATRIC PULMONOLOGY, 2007, : 308 - 309
  • [37] Antimicrobial Properties of Mesenchymal Stem Cells: Therapeutic Potential for Cystic Fibrosis Infection, and Treatment
    Sutton, Morgan T.
    Fletcher, David
    Ghosh, Santosh K.
    Weinberg, Aaron
    van Heeckeren, Rolf
    Kaur, Sukhmani
    Sadeghi, Zhina
    Hijaz, Adonis
    Reese, Jane
    Lazarus, Hillard M.
    Lennon, Donald P.
    Caplan, Arnold I.
    Bonfield, Tracey L.
    STEM CELLS INTERNATIONAL, 2016, 2016
  • [38] DORNASE ALFA - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC POTENTIAL IN CYSTIC-FIBROSIS
    BRYSON, HM
    SORKIN, EM
    DRUGS, 1994, 48 (06) : 894 - 906
  • [39] Unlocking the AhR Therapeutic Potential for Cystic Fibrosis With an Integrated Mucosal Platform for Drug Screening
    Sardelli, Lorenzo
    Frasca, Enrica
    Garbero, Valentina Olga
    Butnarasu, Cosmin
    Affricano, Alex
    Medana, Claudio
    Visentin, Sonja
    ADVANCED THERAPEUTICS, 2024,
  • [40] Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis
    Meijer, Laurent
    Nelson, Deborah J.
    Riazanski, Vladimir
    Gabdoulkhakova, Aida G.
    Hery-Arnaud, Genevieve
    Le Berre, Rozenn
    Loaec, Nadege
    Oumata, Nassima
    Galons, Herve
    Nowak, Emmanuel
    Gueganton, Laetitia
    Dorothee, Guillaume
    Prochazkova, Michaela
    Hall, Bradford
    Kulkarni, Ashok B.
    Gray, Robert D.
    Rossi, Adriano G.
    Witko-Sarsat, Veronique
    Norez, Caroline
    Becq, Frederic
    Ravel, Denis
    Mottier, Dominique
    Rault, Gilles
    JOURNAL OF INNATE IMMUNITY, 2016, 8 (04) : 330 - 349